Medicare Enrolled
Dr. Varinder Singh, MD
Interventional Cardiology · Metuchen, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Varinder Singh is an interventional cardiology specialist in Metuchen, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 7,044 Medicare services across 3,233 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $10,787 from 49 pharmaceutical and/or device companies across 633 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in NJ
$10,787 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,044
Medicare services
Top 8% in NJ for interventional cardiology
3,233
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~371 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,281 | $108 | $210 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,736 | $67 | $120 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
566 | $12 | $35 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
493 | $176 | $400 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
232 | $56 | $145 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
199 | $111 | $230 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
196 | $33 | $75 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
194 | $403 | $800 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
193 | $53 | $195 |
| Injection, dipyridamole, per 10 mg | 189 | $3 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $79 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $143 | $275 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
92 | $142 | $250 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
76 | $116 | $250 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
45 | $61 | $175 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
45 | $34 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
44 | $76 | $120 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
41 | $8 | $30 |
| Cardiac catheterization | 35 | $224 | $500 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
35 | $99 | $180 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $144 | $340 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
25 | $69 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $102 | $180 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $148 | $300 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
15 | $12 | $120 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
15 | $6 | $30 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
11 | $21 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.9% high complexity
16.3% medium
75.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,787
Total received (2018-2024)
Avg $1,541/year across 7 years
Top 37% in NJ for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
633
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,787 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,797
2023
$1,215
2022
$1,591
2021
$2,141
2020
$1,205
2019
$1,037
2018
$1,800
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$294
ShockWave Medical, Inc
$225
AstraZeneca Pharmaceuticals LP
$141
CVRx, Inc.
$133
Bayer Healthcare Pharmaceuticals Inc.
$101
HEARTFLOW, INC.
$91
Penumbra, Inc.
$88
Amgen Inc.
$78
Exact Sciences Corporation
$69
Novartis Pharmaceuticals Corporation
$66
Merck Sharp & Dohme LLC
$58
CeQur Corporation
$54
Lexicon Pharmaceuticals, Inc.
$53
Medtronic, Inc.
$48
Kiniksa Pharmaceuticals International, plc
$45
Novo Nordisk Inc
$36
Baxter Healthcare
$33
Cleerly, Inc.
$32
SANOFI-AVENTIS U.S. LLC
$31
BIOTRONIK INC.
$30
Acist Medical Systems, Inc.
$21
Impulse Dynamics (USA) Inc.
$19
PFIZER INC.
$17
SCPHARMACEUTICALS INC.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Top 3 companies account for 36.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,578
Abbott Laboratories
$940
Novartis Pharmaceuticals Corporation
$903
Amgen Inc.
$707
Amarin Pharma Inc.
$660
BIOTRONIK INC.
$462
Boehringer Ingelheim Pharmaceuticals, Inc.
$415
Boston Scientific Corporation
$411
ShockWave Medical, Inc
$385
E.R. Squibb & Sons, L.L.C.
$337
Janssen Pharmaceuticals, Inc
$324
Medtronic Vascular, Inc.
$302
CVRx, Inc.
$291
Novo Nordisk Inc
$284
SANOFI-AVENTIS U.S. LLC
$256
Bayer Healthcare Pharmaceuticals Inc.
$236
Merck Sharp & Dohme Corporation
$226
PFIZER INC.
$215
Esperion Therapeutics, Inc.
$167
Merck Sharp & Dohme LLC
$155
Bayer HealthCare Pharmaceuticals Inc.
$142
Exact Sciences Corporation
$128
Lilly USA, LLC
$120
Penumbra, Inc.
$114
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$91
HEARTFLOW, INC.
$91
Lexicon Pharmaceuticals, Inc.
$87
Medtronic, Inc.
$75
Shockwave Medical, Inc
$69
BOSTON SCIENTIFIC CORPORATION
$60
Regeneron Healthcare Solutions, Inc.
$58
CeQur Corporation
$54
Kowa Pharmaceuticals America, Inc.
$49
Kiniksa Pharmaceuticals International, plc
$45
ARBOR PHARMACEUTICALS, INC.
$36
Baxter Healthcare
$33
Cleerly, Inc.
$32
Impulse Dynamics (USA) Inc.
$32
Bardy Diagnostics, Inc.
$30
Cardiovascular Systems Inc.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Acist Medical Systems, Inc.
$21
Teleflex LLC
$17
SCPHARMACEUTICALS INC.
$17
Lantheus Medical Imaging, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$16
Gilead Sciences, Inc.
$15
Sunovion Pharmaceuticals Inc.
$14
Althera Pharmaceuticals LLC
$13
Top 3 companies account for 31.7% of all-time payments
Associated products mentioned in payments ›
APTIOM · Acticor · Acticor 7 VR-T DX · Arcalyst · BASAGLAR · BEVESPI AEROSPHERE · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · COROFLOW · CardioMEMS HF System · Carnation Ambulatory Monitor · Catheter - GuideLiner · CeQur Simplicity · Cleerly Ischemia · Cologuard Collection Kit · Corlanor · DEFINITY · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FFRct · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FUROSCIX · FreeStyle Libre 2 · General - Therapies · Hillrom - Carnation Ambulatory Monitor · Indigo System · Inpefa · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · LEQVIO · LifeVest · Livalo · MICRA · MULTAQ · NEXLETOL · ONYX FRONTIER · Optimizer · Optimizer Smart System · Ozempic · PCI Optimization · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Peripheral Orbital Atherectomy System · RESOLUTE ONYX · RESONATE · RXi Consumables · Repatha · Resolute · Roszet · Rybelsus · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · SUPERION · SYMBICORT · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2+ Coronary · Solia · TRADJENTA · TRULICITY · Tresiba · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Victoza · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
97
Per 100K population
11.3
County median income
$109,028
Nearest hospital
RARITAN BAY MEDICAL CENTER
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Singh is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Singh performed 2,281 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $10,787 from 49 companies across 633 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other interventional cardiologists in Metuchen?
Dr. Singh's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Metuchen
Browse interventional cardiologists in Metuchen ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NJ
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NJ
Which NJ interventional cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology